| Literature DB >> 35101011 |
Agostino Di Maro1, Santo Creaco2, Mattia Albini3, Mahfuz Latiff3, Marco Merlo2.
Abstract
BACKGROUND: The Supercapsular percutaneously assisted total hip (SuperPath) technique is a relatively new minimally invasive approach for total hip arthroplasty (THA). Good clinical outcomes related to its use are reported in the literature. Nonetheless, there are still uncertainties about its validity in terms of radiographic outcomes. Main purpose of the study is to evaluate the effectiveness of the SuperPath in acetabular cup positioning through radiographic evaluation of acetabular inclination angle (IA) and acetabular anteversion (AA) angle within the safe zone described by Lewinnek. The leg length discrepancy (LLD), femoral offset (FO), and acetabular offset (AO) were also measured to ascertain the radiographic effectiveness of SuperPath in the acetabular cup placement.Entities:
Mesh:
Year: 2022 PMID: 35101011 PMCID: PMC8802501 DOI: 10.1186/s12891-022-05065-7
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1IA measurement. A case of THA with posteroanterior X-ray image shows the measurement of IA. See text for the description of this angle
Fig. 2AA measurement. A case of THA with cross-table lateral radiograph for the measurement of AA. See text for the description of this angle
Fig. 3LLD, FO, and AO measurements. An example case of THA showing measurements of LLD (yellow lines), FO (blue line), and AO (red line) in posteroanterior X-ray. See text for the description of these measurements
Patients’ demographics
| 719 | |
| Male | 350 |
| Female | 369 |
| 71 (26–104) | |
| 756 | |
| Primary Hip Osteoarthtritis | 454 |
| Secondary Hip Osteoarthtritis | 100 |
| Femoral Head Avascular Necrosis | 70 |
| Developmental Dysplasia of the Hip | 29 |
| Femoral Neck Fracture | 103 |
| 2016 | 164 |
| 2017 | 203 |
| 2018 | 188 |
| 2019 | 201 |
Results of IA
| Years | Inclination angle mean (°) ± SD (range) | Number (%) of hips within the Lewinnek safe zone | ||
|---|---|---|---|---|
| 2016 | 39 ± 8,3 (18,2 - 63,6) | 132 (80) | 2016 vs 2017 | 0,5 |
| 2017 | 42,9 ± 8,3 (21,7 - 63,8) | 166 (82) | ||
| 2018 | 45 ± 8 (22–68,8) | 152 (81) | 2017 vs 2018 | 0,9 |
| 2019 | 43,1 ± 7,3 (26,3 - 62,3) | 170 (85) | ||
| 2016 to 2019 | 42,7 ± 8,2 (18,2 - 68,8) | 620 (82) | 2018 vs 2019 | 0,8 |
Results of AA
| Years | Anteversion angle mean (°) ± SD (range) | Number (%) of hips within the Lewinnek safe zone | ||
|---|---|---|---|---|
| 2016 | 20,2 ± 6,7 (10,1–40) | 125 (76) | 2016 vs 2017 | 0,4 |
| 2017 | 15,3 ± 7,1 (5,4 - 51,2) | 152 (75) | ||
| 2018 | 17,9 ± 8 (9,8 - 59,3) | 149 (79) | 2017 vs 2018 | 0,7 |
| 2019 | 16,1 ± 5,8 (10,5 - 44,6) | 157 (78) | ||
| 2016 to 2019 | 17,6 ± 3,2 (5,4 - 59,3) | 583 (77) | 2018 vs 2019 | 0,6 |
Correlation between the hip disease and radiographic results
| Hip disease | IA mean (°) ± SD (range) | AA mean (°) ± SD (range) | Number (%) of hips within the Lewinnek safe zone | |
|---|---|---|---|---|
| IA | AA | |||
| Primary hip Osteoarthritis | 40,6 ± 5,6 (33,5 - 58,3) | 16 ± 7,9 (14,9 - 31,1) | 381 (84) | 354 (78) |
| Secondary hip Osteoarthritis | 43,9 ± 6,1 (30,4 - 59,6) | 15,4 ± 4,8 (8,9 - 41,3) | 82 (82) | 76 (76) |
| Femoral head avascular necrosis | 39,5 ± 3,7 (20,5 - 65,1) | 14,8 ± 2,5 (5,4 - 40,8) | 56 (80) | 54 (77) |
| Developmental hip dysplasia | 38,1 ± 7,7 (18,2 - 68,8) | 13,2 ± 4,2 (9,8 - 59,3) | 23 (79) | 22 (76) |
| Femoral neck fracture | 40,1 ± 8,9 (22,2 - 63,6) | 16,5 ± 7,1 (9,4 - 46,8) | 82 (80) | 76 (74) |
Results of LLD, FO and AO
| Years | LLD mean (mm) ± SD (range) | FO mean (mm) ± SD (range) | AO mean (mm) ± SD (range) | ||||
|---|---|---|---|---|---|---|---|
| Years | LLD | FO | AO | ||||
| 2016 | 2,5 ± 4,1 (−11; 11) | 44 ± 6,5 (25–60) | 33,7 ± 4,1 (26–44) | 2016 vs 2017 | 0,5 | 0,2 | 0,7 |
| 2017 | 3,9 ± 3,4 (−8; 8) | 45,8 ± 5,5 (38–63) | 33,9 ± 5,2 (24–44) | ||||
| 2018 | 2,2 ± 5,2 (−9; 10) | 45,9 ± 7,6 (31–70) | 33,7 ± 4,9 (26–47) | 2017 vs 2018 | 0,3 | 0,2 | 0,8 |
| 2019 | 2,6 ± 3,6 (− 8; 12) | 46,1 ± 7,2 (34–65) | 34,1 ± 4,8 (27–46) | ||||
| 2016 to 2019 | 2,7 ± 4,8 (− 11; 12) | 45, 7 ± 6,3 (25–70) | 33,8 ± 4,8 (24–47) | 2018 vs 2019 | 0,4 | 0,3 | 0,8 |
Comparison of SuperPath with conventional surgical approaches reported in the recent literature
| Surgical approaches | Number of patients | IA (mean ± SD) (°) | AA (mean ± SD) (°) | |
|---|---|---|---|---|
| SuperPath | 46 | 43,6 ± 6,8 | 17,4 ± 1,6 | |
| Conventional posterior | 46 | 44,5 ± 6,5 | 18,5 ± 1,8 | |
| SuperPath | 12 | 37,08 ± 6,53 | 21,92 ± 5,78 | |
| Posterolateral | 12 | 39, 67 ± 6,95 | 21,75 ± 4,48 | |
| SuperPath | 4 | 38, 75 ± 8,21 | 15 ± 1,82 | |
| Posterolateral | 4 | 44,5 ± 3,64 | 14,25 ± 2,06 | |
| SuperPath | 20 | 36,94 ± 6,37 | 13,94 ± 4,73 | |
| Posterolateral | 20 | 42,66 ± 3,58 | 15,11 ± 4,06 | |
| SuperPath | 25 | 51,2 ± 4,8 | 20,5 ± 9,8 | |
| Hardinge | 23 | 43,77 ± 4,4 | 25 ± 7,9 |